Google
PEN 株価分析 — PENUMBRA INC (Healthcare >> Medical Devices)
PEN に関するよくある質問
PENのPER（株価収益率）は？
PENUMBRA INC（PEN）は現在PER 73.54倍で取引されています。
PENのROE（自己資本利益率）は？
PENUMBRA INCのROEは11.61%です。
PENの配当利回りは？
PENUMBRA INCの配当利回りは0.00%です。
PENの品質スコア（Quality Score）は？
当社のAIはPENの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
PENは今が買い時ですか？
当社AIのタイミングスコアは100点中51点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
PENはどのセクターに属しますか？
PENUMBRA INCはHealthcare >> Medical Devicesセクターに分類されます（NYSE市場）
PEN AI Analysis Summary
Our AI summary for PEN: PENUMBRA INC (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 73.54, ROE of 11.61%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 51/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 321.19
Price
1.36
(0.43%)
Day Change
|
|
|---|
PEN, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
1913
|
| Magic Formula Rank by ROE |
1913
|
| Magic Formula Rank by ROIC |
1755
|
| Price | 321.19 |
| PBV / Sector |
8.54 / -101.57
|
| Earning Per Share | 4.37 |
| PE / Sector |
73.54 / 31.23
|
| PEG or PE/Growth / Sector |
-0.06 / 0.40
|
| Average 1M Daily Value |
125.11 M
GREAT
|
| Average 1W Daily Value |
116.24 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
47% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:19 |
| Symbol | PEN |
| Name | PENUMBRA INC |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 39.33 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 12,579.37 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: One Penumbra Place, Alameda, CA, United States, 94502
Phone: 510 748 3200
Website: https://www.penumbrainc.com
Employees: 4,700
Sector: Healthcare >> Medical Devices
Description: Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
